Awareness of Human Papillomavirus and Its Oncogenic Potential in Head and Neck Cancer among Students: Still More Questions than Answers
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Plummer, M.; De Martel, C.; Vignat, J.; Ferlay, J.; Bray, F.; Franceschi, S. Global burden of cancers attributable to infections in 2012: A synthetic analysis. Lancet Glob. Health 2016, 4, e609–e616. [Google Scholar] [CrossRef] [Green Version]
- Zur Hausen, H. Papillomaviruses in human cancers. Proc. Assoc. Am. Physicians 1999, 111, 581–587. [Google Scholar] [CrossRef]
- Joseph, A.W.; D’souza, G. Epidemiology of Human Papillomavirus-Related Head and Neck Cancer. Otolaryngol. Clin. N. Am. 2012, 45, 739–764. [Google Scholar] [CrossRef] [PubMed]
- Ferlay, J.; Ervik, M.; Lam, F.; Colombet, M.; Mery, L.; Piñeros, M.; Znaor, A.; Soerjomataram, I.; Bray, F. Global Cancer Observatory: Cancer Today; International Agency for Research on Cancer: Lyon, France, 2018; Available online: https://gco.iarc.fr/today (accessed on 1 March 2019).
- Zur Hausen, H. Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression. Lancet 1986, 2, 489–491. [Google Scholar] [PubMed]
- Wierzbicka, M.; Józefiak, A.; Szydłowski, J.; Marszałek, A.; Stankiewicz, C.; Hassman-Poznańska, E.; Osuch-Wójcikiewicz, E.; Składzień, J.; Klatka, J.; Pietruszewska, W.; et al. Recommendations for the diagnosis of human papilloma virus (HPV) high and low risk in the prevention and treatment of diseases of the oral cavity, pharynx and larynx. Guide of experts PTORL and KIDL. Otolaryngol. Polska 2013, 67, 113–134. [Google Scholar] [CrossRef] [PubMed]
- Mehanna, H.M.; Beech, T.; Nicholson, T.; El-Hariry, I.; McConkey, C.; Paleri, V.; Roberts, S. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck 2013, 35, 747–755. [Google Scholar] [CrossRef] [PubMed]
- Lafaurie, G.I.; Perdomo, S.J.; Buenahora, M.R.; Amaya, S.; Díaz-Báez, D. Human papilloma virus: An etiological and prognostic factor for oral cancer? J. Investig. Clin. Dent. 2018, 9, e12313. [Google Scholar] [CrossRef] [PubMed]
- Marur, S.; D’Souza, G.; Westra, W.H.; Forastiere, A.A. HPV-associated head and neck cancer: A virus-related cancer epidemic. Lancet Oncol. 2010, 11, 781–789. [Google Scholar] [CrossRef] [Green Version]
- Mascitti, M.; Tempesta, A.; Togni, L.; Capodiferro, S.; Troiano, G.; Rubini, C.; Maiorano, E.; Santarelli, A.; Favia, G.; Limongelli, L. Histological features and survival in young patients with HPV-negative oral squamous cell carcinoma. Oral Dis. 2020, 26, 1640–1648. [Google Scholar] [CrossRef]
- Heck, J.E.; Berthiller, J.; Vaccarella, S.; Winn, D.M.; Smith, E.M.; Shan’gina, O.; Schwartz, S.M.; Purdue, M.P.; Pilarska, A.; Eluf-Neto, J.; et al. Sexual behaviours and the risk of head and neck cancers: A pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int. J. Epidemiol. 2010, 39, 166–181. [Google Scholar] [CrossRef] [Green Version]
- Smith, E.M.; Ritchie, J.M.; Summersgill, K.F.; Klussmann, J.P.; Lee, J.H.; Wang, D.; Haugen, T.H.; Turek, L.P. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int. J. Cancer 2004, 108, 766–772. [Google Scholar] [CrossRef] [PubMed]
- Blake, K.D.; Ottenbacher, A.J.; Rutten, L.J.F.; Grady, M.A.; Kobrin, S.C.; Jacobson, R.M.; Hesse, B.W. Predictors of human papillomavirus awareness and knowledge 2013: Gaps and opportunities for targeted communication strategies. Am. J. Prev. Med. 2015, 48, 402–410. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- D’Souza, G.; Agrawal, Y.; Halpern, J.; Bodison, S.; Gillison, M.L. Oral Sexual Behaviors Associated with Prevalent Oral Human Papillomavirus Infection. J. Infect. Dis. 2009, 199, 1263–1269. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- D’Souza, G.; Cullen, K.; Bowie, J.; Thorpe, R.; Fakhry, C. Differences in oral sexual behaviors by gender, age, and race explain observed differences in prevalence of oral human papillomavirus infection. PLoS ONE 2014, 9, e86023. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Miller, C.S.; Johnstone, B.M. Human papillomavirus as a risk factor for oral squamous cell carcinoma: A meta-analysis, 1982–1997. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol. 2001, 91, 622–635. [Google Scholar] [CrossRef] [PubMed]
- Sanders, A.E.; Slade, G.D.; Patton, L.L. National prevalence of oral HPV infection and related risk factors in the U.S. adult population. Oral Dis. 2012, 18, 430–441. [Google Scholar] [CrossRef]
- Ribeiro, C.M.B.; Ferrer, I.; De Farias, A.B.S.; Fonseca, D.D.; Silva, I.H.M.; Gueiros, L.A.M.; Carvalho, A.T.; Porter, S.R.; Leão, J.C. Oral and genital HPV genotypic concordance between sexual partners. Clin. Oral Investig. 2013, 18, 261–268. [Google Scholar] [CrossRef]
- Campbell, C.M.P.; Lin, H.-Y.; Fulp, W.J.; Papenfuss, M.R.; Salmerón, J.J.; Quiterio, M.M.; Lazcano-Ponce, E.; Villa, L.L.; Giuliano, A.R. Consistent condom use reduces the genital human papillomavirus burden among high-risk men: The HPV infection in men study. J. Infect. Dis. 2013, 208, 373–384. [Google Scholar] [CrossRef]
- Michaud, D.S.; Fu, Z.; Shi, J.; Chung, M. Periodontal Disease, Tooth Loss, and Cancer Risk. Epidemiol. Rev. 2017, 39, 49–58. [Google Scholar] [CrossRef] [Green Version]
- Gillison, M.L. Current topics in the epidemiology of oral cavity and oropharyngeal cancers. Head Neck 2007, 29, 779–792. [Google Scholar] [CrossRef]
- Bui, T.C.; Tran, L.T.-H.; Markham, C.M.; Huynh, T.T.-T.; Tran, L.T.; Pham, V.T.; Tran, Q.M.; Hoang, N.H.; Hwang, L.-Y.; Sturgis, E.M. Self-reported oral health, oral hygiene, and oral HPV infection in at-risk women in Ho Chi Minh City, Vietnam. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2015, 120, 34–42. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Torre, D.D.; Burtscher, D.; Sölder, E.; Rasse, M.; Puelacher, W. The correlation between the quality of oral hygiene and oral HPV infection in adults: A prospective cross-sectional study. Clin. Oral Investig. 2018, 23, 179–185. [Google Scholar] [CrossRef] [PubMed]
- Meites, E.; Kempe, A.; Markowitz, L.E. Use of a 2-Dose Schedule for Human Papillomavirus Vaccination—Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb. Mortal Wkly. Rep. 2016, 65, 1405–1408. [Google Scholar] [CrossRef] [PubMed]
- Dorleans, F.; Giambi, C.; Dematte, L.; Cotter, S.; Stefanoff, P.; Mereckiene, J.; O’Flanagan, D.; Lopalco, P.L.; D’Ancona, F.; Lévy-Bruhl, D.; et al. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: First results of the VENICE2 2010 survey. Eurosurveillance 2010, 15. [Google Scholar] [CrossRef] [Green Version]
- Ganczak, M.; Owsianka, B.; Korzeń, M. Factors that Predict Parental Willingness to Have Their Children Vaccinated against HPV in a Country with Low HPV Vaccination Coverage. Int. J. Environ. Res. Public Health 2018, 15, 645. [Google Scholar] [CrossRef] [Green Version]
- Hall, M.; Simms, K.T.; Lew, J.-B.; A Smith, M.; Brotherton, J.M.; Saville, M.; Frazer, I.H.; Canfell, K. The projected timeframe until cervical cancer elimination in Australia: A modelling study. Lancet Public Health 2019, 4, e19–e27. [Google Scholar] [CrossRef] [Green Version]
- Kreimer, A.R.; Struyf, F.; Del Rosario-Raymundo, M.R.; Hildesheim, A.; Skinner, S.R.; Wacholder, S.; Garland, S.M.; Herrero, R.; David, M.-P.; Wheeler, C.M.; et al. Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: Combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials. Lancet Oncol. 2015, 16, 775–786. [Google Scholar] [CrossRef] [Green Version]
- Kreimer, A.R.; Rodriguez, A.C.; Hildesheim, A.; Herrero, R.; Porras, C.; Schiffman, M.; González, P.; Solomon, D.; Jiménez, S.; Schiller, J.T.; et al. CVT Vaccine Group. Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine. J. Natl. Cancer Inst. 2011, 103, 1444–1451. [Google Scholar] [CrossRef]
- Sankaranarayanan, R.; Prabhu, P.R.; Pawlita, M.; Gheit, T.; Bhatla, N.; Muwonge, R.; Nene, B.M.; Esmy, P.O.; Joshi, S.; Poli, U.R.R.; et al. Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: A multicentre prospective cohort study. Lancet Oncol. 2016, 17, 67–77. [Google Scholar] [CrossRef] [Green Version]
- McBride, K.R.; Singh, S. Predictors of Adults’ Knowledge and Awareness of HPV, HPV-Associated Cancers, and the HPV Vaccine: Implications for Health Education. Health Educ. Behav. 2017, 45, 68–76. [Google Scholar] [CrossRef]
- Taberna, M.; Inglehart, R.C.; Pickard, R.K.L.; Fakhry, C.; Agrawal, A.; Katz, M.L.; Gillison, M.L. Significant changes in sexual behavior after a diagnosis of human papillomavirus-positive and human papillomavirus-negative oral cancer. Cancer 2017, 123, 1156–1165. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Landgren, R.; Shelal, Z.; Bernard, C.; Urbauer, D.; Toy, E.; Ramondetta, L. Human Papillomavirus: From Basic Science to Clinical Management for Preclinical Medical Students. MedEdPORTAL 2018, 14, 10787. [Google Scholar] [CrossRef]
QUESTION | ANSWER | Medical Students | Non-Medical Students | ||
---|---|---|---|---|---|
N | % | N | % | ||
Have you ever heard about Human Papilloma Virus (HPV)? | YES | 908 | 96.39% | 456 | 59.38% |
NO | 34 | 3.61% | 312 | 40.63% | |
Σ | 942 | 768 | |||
Can you get infected with HPV? | YES | 876 | 96.48% | 394 | 86.40% |
NO | 9 | 0.99% | 4 | 0.88% | |
DON’T KNOW | 23 | 2.53% | 58 | 12.72% | |
Are there any vaccines against Human Papilloma Virus (HPV)? | YES | 646 | 71.15% | 204 | 44.74% |
NO | 61 | 6.72% | 41 | 8.99% | |
DON’T KNOW | 201 | 22.14% | 211 | 46.27% | |
Can Human Papilloma Virus (HPV) cause a disease? | YES | 828 | 91.19% | 357 | 78.29% |
NO | 10 | 1.10% | 10 | 2.19% | |
DON’T KNOW | 70 | 7.71% | 89 | 19.52% | |
Can human papilloma virus (HPV) infection lead to cancer? | YES | 737 | 81.17% | 255 | 55.92% |
NO | 17 | 1.87% | 23 | 5.04% | |
DON’T KNOW | 154 | 16.96% | 178 | 39.04% | |
Σ | 908 | 456 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Jeruzal-Świątecka, J.; Pietruszewska, W. Awareness of Human Papillomavirus and Its Oncogenic Potential in Head and Neck Cancer among Students: Still More Questions than Answers. Int. J. Environ. Res. Public Health 2020, 17, 8667. https://doi.org/10.3390/ijerph17228667
Jeruzal-Świątecka J, Pietruszewska W. Awareness of Human Papillomavirus and Its Oncogenic Potential in Head and Neck Cancer among Students: Still More Questions than Answers. International Journal of Environmental Research and Public Health. 2020; 17(22):8667. https://doi.org/10.3390/ijerph17228667
Chicago/Turabian StyleJeruzal-Świątecka, Joanna, and Wioletta Pietruszewska. 2020. "Awareness of Human Papillomavirus and Its Oncogenic Potential in Head and Neck Cancer among Students: Still More Questions than Answers" International Journal of Environmental Research and Public Health 17, no. 22: 8667. https://doi.org/10.3390/ijerph17228667